GUIDANCE OF GANCICLOVIR THERAPY WITH pp65 ANTIGENEMIA IN CYTOMEGALOVIRUS-FREE RECIPIENTS OF LIVERS FROM SEROPOSITIVE DONORS

類似資料

• Ganciclovir for Invasive Cytomegalovirus Infection in Renal Allograft Recipients
  著者:: Hrebinko, R., 等
  出版事項: (1991)
• A Multisite Trial Comparing Two Cytomegalovirus (CMV) pp65 Antigenemia Test Kits, Biotest CMV Brite and Bartels/Argene CMV Antigenemia
  著者:: St. George, Kirsten, 等
  出版事項: (2000)
• A PROSPECTIVE RANDOMIZED TRIAL COMPARING SEQUENTIAL GANCICLOVIR-HIGH DOSE ACYCLOVIR TO HIGH DOSE ACYCLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN ADULT LIVER TRANSPLANT RECIPIENTS
  著者:: Martin, Maureen, 等
  出版事項: (1994)
• Prospective study of cytomegalovirus antigenemia in allograft recipients.
  著者:: Miller, H, 等
  出版事項: (1991)
• THERAPEUTIC USE OF GANCICLOVIR FOR INVASIVE CYTOMEGALOVIRUS INFECTION IN CADAVERIC RENAL ALLOGRAFT RECIPIENTS
  著者:: Jordan, Mark L., 等
  出版事項: (1992)